Dear Scientist,
In search of a reliable CRISPR edited cancer biomarker cell line relevant to diseases and drug targets? GeneCopoeia's OncoSpot™ Cancer Biomarker Mutant Cell Lines offer a variety of premade options. These mutations are engineered using CRISPR technology to generate either a homozygous or heterozygous cell line.
| Features: |
Hot spot mutations in tumor biomarkers,
including EGFR, KRAS, & BRAF |
|
Isolated from single cell clones
|
|
Sanger sequence verified
|
|
Parental cell line included
|
|
Premade and ready to ship |
|
| Application: |
Study molecular and cellular
mechanisms |
|
Monitoring cancer signaling pathways
|
|
Drug discovery
|
|
Compound screening
|
|
Functional characterization |
|
|
| |
| OncoSpot™ Cancer Biomarker Mutant Cell Lines
|
|
Catalog #
|
Gene
|
Mutation
|
Zygosity
|
| SL701
|
EGFR
|
ΔE746-A750
|
Homozygous
|
| SL702
|
Heterozygous
|
| SL703
|
EGFR |
L858R
|
Homozygous
|
| SL704
|
Heterozygous
|
| SL705
|
BRAF
|
V600E
|
Homozygous
|
| SL706
|
Heterozygous
|
| SL710
|
KRAS
|
G13C
|
Homozygous
|
| SL711
|
Heterozygous
|
| Don't see what you're looking for? We also offer custom cell line services! |
| Please contact us at inquiry@genecopoeia.com to get a quote.
|
Contact us:
Phone: 1-866-360-9531
Email: inquiry@genecopoeia.com
www.genecopoeia.com
|
|
9620 Medical Center Drive, Rockville, MD 20850
If you do not wish to receive special offers or informational
emails, please click here |
|
|
|
|
